Dr. Lori L. Davis, MD
Psychiatry (Psychiatry Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Psychiatry Physician primary
AL license 16949
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 3 companies reported 48 payments worth $56,968 in total to this clinician.
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $56,160 |
|---|---|
| Otsuka America Pharmaceutical, Inc. | $675 |
| Lundbeck LLC | $134 |
| Consulting Fee | $49,696 |
|---|---|
| Travel and Lodging | $6,447 |
| Food and Beverage | $825 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jul 23, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $9,855 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 4, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $9,720 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 6, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $6,588 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 6, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $4,050 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Apr 16, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $3,796 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 4, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $3,780 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 30, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $3,240 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 4, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $2,916 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jul 23, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $2,592 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 30, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $1,080 |
All 30 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. Dec 15, 2025 | Consulting Fee | $540 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Oct 20, 2025 | Consulting Fee | $540 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jul 23, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $9,855 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jul 23, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $2,592 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jul 11, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $324 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 30, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $3,240 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 30, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $1,080 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 4, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $9,720 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jun 4, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $2,916 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Apr 16, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $3,796 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Mar 20, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to COLORADO SPRINGS, CO | $23.90 |
| Otsuka America Pharmaceutical, Inc. Mar 4, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $675 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 21, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to PRINCETON, NJ · in-kind | $479 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 21, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to PRINCETON, NJ · in-kind | $275 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 19, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to PRINCETON, NJ · in-kind | $575 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 19, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to PRINCETON, NJ · in-kind | $275 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 13, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to BIRMINGHAM, AL | $627 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 13, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to PRINCETON, NJ · in-kind | $410 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 13, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to PRINCETON, NJ · in-kind | $223 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 11, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to PRINCETON, NJ · in-kind | $1,007 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 11, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to PRINCETON, NJ · in-kind | $223 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 6, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $6,588 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 6, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $4,050 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 6, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to COLORADO SPRINGS, CO | $407 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 6, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to BIRMINGHAM, AL | $48.00 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 6, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to COLORADO SPRINGS, CO | $40.00 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 4, 2025 | Consulting Fee REXULTI · PSYCHIATRY | $3,780 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Feb 4, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to BOSTON, MA | $849 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jan 3, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to BOSTON, MA | $943 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jan 3, 2025 | Travel and Lodging REXULTI · PSYCHIATRY · travel to BIRMINGHAM, AL | $41.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $21,652 in research payments for these studies, mostly to the institutions running them.
- Impact of Telehealth Services Utilization During COVID-19 on Treatment Patterns and Outcomes among Veterans with AUD
Alkermes, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.